MedTrace Logo

A Comparison of Single-Stage Full-Mouth Disinfection With Quadrant-Based Scaling and Root Planing in Patients With Uncontrolled Type 2 Diabetes and Severe Periodontitis: An Assessment of Its Impact on Quality of Life

NCT07598071 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2026-05-20

No results posted yet for this study

Summary

This study evaluated the effects of a single-stage full mouth disinfection (FMD) protocol versus a quadrant-based tooth surface cleaning and root planing (Q-SRP) protocol on changes in clinical periodontal parameters over a 3-month period, as well as on the social, psychological and functional well-being of patients with poorly controlled type 2 diabetes and severe periodontitis.

Conditions

  • Uncontrolled Type 2 Diabetes Mellitus
  • Severe Periodontitis

Interventions

PROCEDURE

Quadrant based scaling and root planning

Quadrant-Based Treatment treats one quadrants at a time over four weeks

PROCEDURE

full mouth disinfeciton

Full Mouth Disinfection involves scaling and root planing all teeth within 24 hours, often paired with intensive antiseptics to prevent re-infection from remaining pockets

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Principal Investigators

  • Gizem Torumtay Cin, Assoc. Prof. · Pamukkale University, Faculty of Dentistry, Department of Periodontology

  • Emine Ece Barlay · Pamukkale University Faculty of Dentistry, Department of Periodontology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-13
Primary Completion
2026-03-03
Completion
2026-03-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07598071 on ClinicalTrials.gov